N-acetylcysteine inhibits kinase phosphorylation during 3T3-L1 adipocyte differentiation

Daniela Soto1, María Gomez-Serrano2, Azul Pieralisi1

  • 1a Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales , Universidad de Buenos Aires - IQUIBICEN, CONICET , Buenos Aires , Argentina.

Abstract

Insights

N-acetylcysteine (NAC) inhibits adipocyte differentiation by reducing triglyceride accumulation and mitochondrial protein expression. This antioxidant prevents mitotic clonal expansion and key kinase phosphorylation, offering potential therapeutic insights for obesity.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Metabolism

Background:

  • Antioxidant effects on obesity are debated.
  • N-acetylcysteine (NAC) previously inhibited triglyceride accumulation and MAOA expression in adipocytes.
  • The role of NAC in adipogenic differentiation requires further investigation.

Purpose of the Study:

  • To analyze the role of NAC in the adipogenic differentiation pathway.
  • To evaluate the effects of NAC on key signaling molecules and mitochondrial proteins during adipocyte differentiation.

Main Methods:

  • 3T3-L1 preadipocytes were differentiated into mature adipocytes.
  • Differentiated cells were treated with varying doses of NAC (0.01 or 1 mM).
  • Expression of phospho-JNK½, phospho-ERK½, and mitochondrial proteins (citrate synthase, fumarate hydratase, MAOA) was assessed.

Main Results:

  • Differentiation increased phospho-JNK½ and phospho-ERK½ expression and mitotic clonal expansion (MCE).
  • NAC treatment decreased phospho-JNK½ and phospho-ERK½ levels.
  • NAC significantly inhibited MCE and altered mitochondrial protein expression.

Conclusions:

  • NAC inhibits adipogenesis by preventing MCE and kinase phosphorylation.
  • NAC reduces triglyceride and mitochondrial protein accumulation.
  • These findings suggest NAC's potential in managing obesity-related metabolic dysfunction.